Tobacco Control

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Tobacco Control 2006;15:1-2; doi:10.1136/tc.2005.014381
Copyright © 2006 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eissenberg, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eissenberg, T
Related Collections
Right arrow Tobacco use
Right arrow Health effects of tobacco use
Right arrow Smoking cessation

EDITORIAL

Potential reduced exposure products

The time for tobacco industry sponsored PREP evaluation has arrived

T Eissenberg

Correspondence to:
Thomas Eissenberg
Virginia Commonwealth University, Richmond, VA 23298, USA; teissenb@vcu.edu


Rigorous and objective industry funded evaluation of potential reduced exposure products will require innovation and flexibility, but must begin now

Keywords: tobacco; potential reduced exposure products; evaluation

The first 150 words of the full text of this article appear below.

Potential reduced exposure products (PREPs) for smokers are marketed by the tobacco industry as a way for smokers to reduce toxicant intake while continuing to use tobacco.1 In the past, similarly marketed products, so called "low yield" cigarettes, were financial successes but public health failures.1,2 Deceptive marketing of these early PREPs helps to explain their financial success,3 while a lack of objective pre-market evaluation of users’ smoke toxicant exposure helps to explain their public health failure.1,4 Given this history, anyone interested in public health is correct to be sceptical of the marketing that surrounds a new generation of PREPs in the USA (for example, Accord®, AdvanceTM, Aeros®, Eclipse®, Quest®) and Europe (for example, NicStic®). Even more important, public health advocates are correct to insist that PREPs be evaluated comprehensively, rigorously, and objectively.1,5 This type of evaluation will help ensure that . . . [Full text of this article]




This article has been cited by other articles:


Home page
J Pediatr PsycholHome page
G. E. Matt, J. T. Bernert, and M. F. Hovell
Measuring Secondhand Smoke Exposure in Children: An Ecological Measurement Approach
J. Pediatr. Psychol., March 1, 2008; 33(2): 156 - 175.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd.